Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urinary Bladder Urothelial Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05276167
What this trial is testing

Hyperthermic Intravesical Perfusion for Muscle-invasive Bladder Urothelial Carcinoma

Who this might be right for
High-Risk, Non-Muscle Invasive Bladder Urothelial CarcinomaPerfusion; ComplicationsIntraoperative Complications
Henan Cancer Hospital 40
Not applicableLooking for participantsNCT06167356
What this trial is testing

Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.

Who this might be right for
Non Muscle Invasive Bladder CancerNon-Muscle Invasive Bladder NeoplasmsNon-Muscle Invasive Bladder Urothelial Carcinoma+8 more
IRCCS San Raffaele 20,000
Not applicableNot Yet RecruitingNCT06675656
What this trial is testing

Predictive Role of Microbiome in Patients With Urothelial Carcinoma

Who this might be right for
Urinary Bladder Cancer
IRCCS San Raffaele 420
Early research (Phase 1)Study completedNCT02318329
What this trial is testing

Open-Label, Dose-Finding Study Evaluating Safety and PK of FPA144 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsGastric CancerTransitional Cell Carcinoma of the Bladder
Five Prime Therapeutics, Inc. 79
Early research (Phase 1)Study completedNCT00536588
What this trial is testing

A Safety and Tolerability Study of SCH 721015 in Patients With Transitional Cell Carcinoma of the Bladder (Study P03816)

Who this might be right for
Bladder Neoplasms
Merck Sharp & Dohme LLC 17
Large-scale testing (Phase 3)Ended earlyNCT00384891
What this trial is testing

Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer

Who this might be right for
Urinary Bladder DiseasesUrinary Bladder NeoplasmsUrinary Bladder Cancer+5 more
Medical Enterprises Europe B.V. 190
Testing effectiveness (Phase 2)Active Not RecruitingNCT05535218
What this trial is testing

Pembrolizumab-Sacituzumab Govitecan Combination to Treat High-risk, Localized Bladder Cancer

Who this might be right for
Muscle-invasive Urothelial Carcinoma of the Bladder
Claudia Guerrieri 48
Early research (Phase 1)WithdrawnNCT05259397
What this trial is testing

PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Bladder Cancer
Pfizer
Early research (Phase 1)Ended earlyNCT03106610
What this trial is testing

Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)UnknownNCT02278978
What this trial is testing

BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
National Taiwan University Hospital 129
Testing effectiveness (Phase 2)Ended earlyNCT01215136
What this trial is testing

First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma

Who this might be right for
Transitional Cell CarcinomaBladder CarcinomaUrothelial Carcinoma
Matthew Galsky 36
Not applicableLooking for participantsNCT06818136
What this trial is testing

Bladder EpiCheck European Haematuria Study

Who this might be right for
HematuriaCystoscopyUrothelial Carcinoma Bladder+2 more
Nucleix Ltd. 800
Testing effectiveness (Phase 2)Study completedNCT01824329
What this trial is testing

Prostate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Carcinoma of the Bladder
University of Michigan 40
Not applicableLooking for participantsNCT07029256
What this trial is testing

Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)

Who this might be right for
Bladder Urothelial Carcinoma
Mayo Clinic 100
Testing effectiveness (Phase 2)Ended earlyNCT00004856
What this trial is testing

Trastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothelium

Who this might be right for
Distal Urethral CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterProximal Urethral Cancer+6 more
National Cancer Institute (NCI) 40
Not applicableActive Not RecruitingNCT04167631
What this trial is testing

Can VI-RADS/ADC Accurately Stage Bladder Cancer??

Who this might be right for
MRI Contrast Media Adverse ReactionBladder CancerBladder Disease+4 more
Mansoura University 150
Early research (Phase 1)Study completedNCT05524545
What this trial is testing

Evorpacept (ALX148) With Enfortumab Vedotin for Subjects With Urothelial Carcinoma (ASPEN-07)

Who this might be right for
Bladder CancerUrothelial Carcinoma
ALX Oncology Inc. 36
Testing effectiveness (Phase 2)Study completedNCT01426126
What this trial is testing

Study of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platinum

Who this might be right for
Bladder CancerUreter Cancer
Asan Medical Center 37
Large-scale testing (Phase 3)Looking for participantsNCT06493552
What this trial is testing

Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors

Who this might be right for
Muscle-Invasive Bladder CarcinomaMetastatic Urothelial Carcinoma
Vasgene Therapeutics, Inc 700
Large-scale testing (Phase 3)Active Not RecruitingNCT05243550
What this trial is testing

Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder
UroGen Pharma Ltd. 240
Next Page